High HLA-DP Expression and Graft-versus-Host Disease
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Transplantation of hematopoietic cells from unrelated donors can cure blood disorders but carries a significant risk of acute graft-versus-host disease (GVHD). The risk is higher when the recipient and donor are HLA-DPB1-mismatched, but the mechanisms leading to GVHD are unknown. The HLA-DPB1 regulatory region variant rs9277534 is associated with HLA-DPB1 expression. We tested the hypothesis that the GVHD risk correlates with the rs9277534 allele linked to the mismatched HLA-DPB1 in the recipient. METHODS: We genotyped rs9277534 in 3505 persons to define rs9277534-DPB1 haplotypes. Among 1441 recipients of transplants from HLA-A,B,C,DRB1,DQB1-matched unrelated donors with only one HLA-DPB1 mismatch, linkage of the rs9277534 A and G alleles to the mismatched HLA-DPB1 was determined. HLA-DPB1 expression was assessed by means of a quantitative polymerase-chain-reaction assay. The risk of acute GVHD among recipients whose mismatched HLA-DPB1 allele was linked to rs9277534G (high expression) was compared with the risk among recipients whose mismatched HLA-DPB1 allele was linked to rs9277534A (low expression). RESULTS: The mean HLA-DPB1 expression was lower with rs9277534A than with rs9277534G. Among recipients of transplants from donors with rs9277534A-linked HLA-DPB1, the risk of acute GVHD was higher for recipients with rs9277534G-linked HLA-DPB1 mismatches than for recipients with rs9277534A-linked HLA-DPB1 mismatches (hazard ratio, 1.54; 95% confidence interval [CI], 1.25 to 1.89; P<0.001), as was the risk of death due to causes other than disease recurrence (hazard ratio, 1.25; 95% CI, 1.00 to 1.57; P=0.05). CONCLUSIONS: The risk of GVHD associated with HLA-DPB1 mismatching was influenced by the HLA-DPB1 rs9277534 expression marker. Among recipients of HLA-DPB1-mismatched transplants from donors with the low-expression allele, recipients with the high-expression allele had a high risk of GVHD. (Funded by the National Institutes of Health and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mismatched HLA-DP has been shown to be associated with graft-versus-host disease (47).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190
Graft-versus-leukemia reactions after bone marrow transplantation
Horowitz, M., Gale, R., Sondel, P., Goldman, J., Kersey, J., Kolb, H., Rimm, A., Ringden, O., Rozman, C., & Speck, B. (1990) · Blood · doi:10.1182/blood.v75.3.555.555 · Cited by 2,774
Self-citationFord, R., & Eisenberg, S. (1990) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02934-6 · Cited by 2,720
Lee, S. J., Klein, J., Haagenson, M., Baxter-Lowe, L. A., Confer, D. L., Eapen, M., Fernandez-Vina, M., Flomenberg, N., Horowitz, M., Hurley, C. K., et al. (2007) · Blood · doi:10.1182/blood-2007-06-097386 · Cited by 1,255
Self-citationHematopoietic Cell Transplantation
Forman, S. J., & Nakamura, R. (2015) · Blackwell Science Ltd eBooks · Cited by 659
Sasazuki, T., Juji, T., Morishima, Y., Kinukawa, N., Kashiwabara, H., Inoko, H., Yoshida, T., Kimura, A., Akaza, T., Kamikawaji, N., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391701 · Cited by 526
Kamatani, Y., Wattanapokayakit, S., Ochi, H., Kawaguchi, T., Takahashi, A., Hosono, N., Kubo, M., Tsunoda, T., Kamatani, N., Kumada, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.348 · Cited by 516
Influence of HLA-C Expression Level on HIV Control
Apps, R., Qi, Y., Carlson, J. M., Chen, H., Gao, X., Thomas, R., Yuki, Y., Del Prete, G. Q., Goulder, P., Brumme, Z. L., et al. (2013) · Science · doi:10.1126/science.1232685 · Cited by 371
Self-citationFleischhauer, K., Shaw, B. E., Gooley, T., Malkki, M., Bardy, P., Bignon, J.-D., Dubois, V., Horowitz, M. M., Madrigal, J. A., Morishima, Y., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70004-9 · Cited by 357
Self-citationMajor-Histocompatibility-Complex Class I Alleles and Antigens in Hematopoietic-Cell Transplantation
Petersdorf, E. W., Hansen, J. A., Martin, P. J., Woolfrey, A., Malkki, M., Gooley, T., Storer, B., Mickelson, E., Smith, A., & Anasetti, C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011826 · Cited by 335
Self-citation
Cited by
Items 201–300 of 309
Dubois, V., Brignier, A., Elsermans, V., Gagne, K., Kennel, A., Pédron, B., Picard, C., Ravinet, A., Varlet, P., Cesbron, A., et al. (2016) · Bulletin du Cancer · doi:10.1016/j.bulcan.2016.09.005 · Cited by 5
Hiramatsu, K., Matsuda, H., Nemoto, T., Nosaka, T., Saitō, Y., Naito, T., Takahashi, K., Ofuji, K., Ohtani, M., Suto, H., et al. (2017) · Journal of Medical Virology · doi:10.1002/jmv.24814 · Cited by 5
What compatibility in 2017 for the haematopoietic stem cell transplantation?
Lafarge, X. (2017) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2017.06.006 · Cited by 5
Andreani, M., Gaspari, S., & Locatelli, F. (2019) · International Journal of Immunogenetics · doi:10.1111/iji.12459 · Cited by 5
How I select hematopoietic cell donors in the era of posttransplant cyclophosphamide
Shaffer, B. C., Lee, S. J., & Perales, M. (2026) · Blood · doi:10.1182/blood.2025030823 · Cited by 4
Meng, Y., Wang, Q., Shi, L., Yan, Q., He, Q., Ruan, P., Chen, Z., Wang, D., Qu, H., Chen, P., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70725-4 · Cited by 4
“For example, HLA-DP has been identi fi ed as a ligand for NKp44 57 and is associated with graft-versus-host disease 58 .”
Mizutani, A., Suzuki, S., Shigenari, A., Sato, T., Tanaka, M., Kulski, J. K., & Shiina, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1332636 · Cited by 4
“Some of these investigations encompassed disease associations, such as the correlation of class I gene expression with ankylosing spondylitis (21), HIV control (22 – 25), Crohn ’ s disease (25), and acute graft-versus-host disease (GVHD) (26).”
BackgroundPeton, B., Taniguchi, M., Mangiola, M., Malki, M. M. A., & Gendzekhadze, K. (2023) · HLA · doi:10.1111/tan.15192 · Cited by 4
“15 Previous studies have shown that variable levels of HLA-C and HLA-DPB1 can affect GVHD. 16,17 Levels of HLA expression have also been implicated in the density and spatial organization of HLA molecules on the cell surface, 18 and studies have indicated the vital role of HLA-A and HLA-C…”
BackgroundGrønvold, B., Ali, M. M., Remberger, M., Mattsson, J., EGELAND, T., Lundin, K. U., Myhre, A. E., Abrahamsen, I. W., Heldal, D., Dybedal, I., et al. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-0827-3 · Cited by 4
Adachi, Y., Sakai, T., Terakura, S., Shiina, T., Suzuki, S., Hamana, H., Kishi, H., Sasazuki, T., Arase, H., Hanajiri, R., et al. (2022) · International Journal of Hematology · doi:10.1007/s12185-021-03273-w · Cited by 4
“Because there is accumulating evidence that HLAclass II expression is important in acute graft-versus-host disease and post-transplant relapse [10, 30, 31], we next investigated the recognition of Ag-specific T cells associated with HLA-class II downregulation.”
BackgroundSpierings, E., Madrigal, J. A., & Fleischhauer, K. (2024) · Springer eBooks · doi:10.1007/978-3-031-44080-9_9 · Cited by 3
Wenger, V., & Zeiser, R. (2024) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2024.101567 · Cited by 3
Truong, L., Matern, B. M., El‐Lagta, N., Mobegi, F. M., Askar, M. Z., Öğret, Y., Oğuz, F. S., Kwok, J., D'Orsogna, L. J. A., Martínez, P., et al. (2023) · HLA · doi:10.1111/tan.15155 · Cited by 3
Self-citationHiding in plain sight: Misinterpretation of immunogenic DPB epitopes within G/P groups
Morris, A. B., Achram, R., Sullivan, H. C., Gebel, H. M., & Bray, R. A. (2024) · Human Immunology · doi:10.1016/j.humimm.2024.111115 · Cited by 3
Laghmouchi, A., Hoogstraten, C., Falkenburg, J. H. F., & Jedema, I. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.03.001 · Cited by 3
The HLA System in Hematopoietic Stem Cell Transplantation
Petersdorf, E. W., & Socié, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812630-1.00002-5 · Cited by 3
Self-citationGetz, J., Goldenstein, M., Bonfim, C., Funke, V. A. M., Colturato, V. A. R., Hamerschlak, N., Torres, M. A., Sayer, D. C., Boldt, A. B. W., Pasqüini, R., et al. (2019) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2019.06.004 · Cited by 3
Yin, Y., Soe, N. N., Valenzuela, N. M., Reed, E. F., & Zhang, Q. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1328533 · Cited by 2
Landscapes of HLA Mismatching in Contemporary Unrelated Haematopoietic Cell Transplantation
Arrieta‐Bolaños, E., Bonneville, E. F., Crivello, P., Gedde‐Dahl, T., de Latour, R. P., Salmenniemi, U., Kröger, N. M., Yakoub‐Agha, I., Zecca, M., Choi, G., et al. (2026) · HLA · doi:10.1111/tan.70637 · Cited by 2
“An alternative model for the assessment of tolerable mismatches at HLA-DPB1 based on the level of expression of single GvH mis-matches [37, 38] has a partial overlap with the TCE model [46].”
Tools for optimizing risk assessment in hematopoietic cell transplant – What can we get away with?
Hod-Dvorai, R., & Cusick, M. F. (2022) · Human Immunology · doi:10.1016/j.humimm.2022.01.010 · Cited by 2
The human leukocyte antigen system in human disease and transplantation medicine
Sharma, G., Baranwal, A. K., & Mehra, N. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809356-6.00017-4 · Cited by 2
The HLA System in Transfusion Medicine and Transplantation
Choo, S. Y. (2021) · Transfusion Medicine · doi:10.1002/9781119599586.ch18 · Cited by 2
Quality and Safety in Hematopoietic Stem Cell Transplant Patients
Ruble, K., Krupski, C., Chen, A. R., & Dandoy, C. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-53790-0_17 · Cited by 2
Robert, S., Albring, J. C., Frebel, K., Opitz, C., Urh, J., Wolf, C., Heinrich, C., Berdel, W. E., & Stelljes, M. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-017-0071-7 · Cited by 2
Katsuyama, N., Kawase, T., Barakat, C., Mizuno, S., Tomita, A., Ozeki, K., Nishio, N., Sato, Y., Kajiya, R., Shiraishi, K., et al. (2023) · PubMed Central · doi:10.18999/nagjms.85.4.779 · Cited by 2
HLA Class II Allele Polymorphisms and the Clinical Outcomes of HBV Infection
Zhang, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81366 · Cited by 2
“By influencing HLA mRNA expression, rs3077 and rs9277535 variants, both are noncoding variation (3′UTR) in the HLA-DPA1 and HLA-DPB1 region, and are related to enhanced clearance of hepatitis B virus infection [57, 63] and increased risk of graft-versus-host disease in mismatched hematopoietic cell transplant recipien…”
BackgroundCrocchiolo, R., Mele, L., Testi, M., Scollo, C. M., Murgia, B., Rossi, A., Vecchiato, C., Grammatico, P., Mininni, D., Longhi, E., et al. (2021) · HLA · doi:10.1111/tan.14347 · Cited by 2
Novel Tools for the Study of HLA Class II Cross-isotype Pairings
Hidalgo, L. G. (2024) · Transplantation · doi:10.1097/tp.0000000000005041 · Cited by 1
Li, F., Niu, B., Huang, Y., Zhu, M., Liu, L., Chen, L., Yang, H. U. I., 秦波音, & Zhou, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1798003 · Cited by 1
“Speci fi c HLA-DP allotypes, along with the expression levels of HLA-DP molecules, have been associated to many human diseases, including graft-versus-host disease (21), hepatitis B virus (HBV) infection (22, 23), HIV (24, 25) and autoimmune diseases (15, 18, 26).”
A Tool for the Assessment of HLA-DQ Heterodimer Variation in Hematopoietic Cell Transplantation
Sajulga, R., Bolon, Y., Maiers, M. J., & Petersdorf, E. W. (2024) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2024.08.006 · Cited by 1
Self-citationPassweg, J. R., & Kalberer, C. P. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.06.021 · Cited by 1
Biomarkers in Immune Disorders
Jain, K. K. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7431-3_7 · Cited by 1
Burmistrova, A. L., Николаевич, В. М., Хромова, Е. Б., & Суслова, Т. А. (2019) · HLA · doi:10.1111/tan.13765 · Cited by 1
“Тhe level of HLA-DP expression in the patient influences the incidence of GvHD after HSCT, where mismatching against a highly-expressed patient allele leads to significantly higher GvHD risk compared to other combinations.(17,18) Single nucleotide polymorphism in the 30 untranslated region of HLA-DPB1, rs9277534, is a…”
BackgroundCornillon, J., Crocchiolo, R., Dubois, V., Guidicelli, G., Cordeiro, D. J., Meunier, M., Michiels, S., Timmermans, A. D., Villemonteix, J., Yakoub‐Agha, I., et al. (2023) · Bulletin du Cancer · doi:10.1016/j.bulcan.2023.07.008 · Cited by 1
New HLA-DPB1 T-cell epitope model for mismatched UR-HCT
Morishima, S. (2024) · Blood · doi:10.1182/blood.2024026286 · Cited by 1
Dandoy, C. E., Hilden, J. M., Billett, A. L., & Mueller, B. U. (2017) · Springer eBooks · doi:10.1007/978-3-319-53790-0_1 · Cited by 1
HLA Typing in Support of Hematopoietic Cell Transplantation from Unrelated Donors
Petersdorf, E. W., Anasetti, C., Martin, P. J., & Hansen, J. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-64263-5_56 · Cited by 1
Self-citationNew development of HLA research in allogeneic hematopoietic cell transplantation
Morishima, S. (2024) · Japanese Journal of Transplantation and Cellular Therapy · doi:10.7889/tct-24-001 · Cited by 1
Human Leukocyte Antigen Genotyping for Allogeneic Transplantations
DUFFY, B. F., Tang, M. S., & Liu, C. (2024) · Wiley eBooks · doi:10.1002/9781683674023.ch112 · Cited by 1
Petersdorf, E. W. (2025) · Wiley eBooks · doi:10.1002/9783527847617.ch11 · Cited by 1
Self-citationKawase, T., Kanda, J., Onizuka, M., Morishima, S., Morishima, Y., Uchida, N., Uehara, Y., Takahashi, S., Eto, T., Kobayashi, H., et al. (2025) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2025.09.045 · Cited by 1
Pidala, J., & Anasetti, C. (2022) · Haematologica · doi:10.3324/haematol.2022.281168 · Cited by 1
“relapse mortality.(2-5) The paper reports a significant interaction between high HLA-DPB1 expression in the host and donor HLA-DPB1 TCE-permissiveness in opposing directions, with lower mortality associated with donor TCE-permissiveness in the highexpression recipient group despite increased GVHD and decreased leukemi…”
BackgroundKrajinović, M., Mootoosamy, C., Ansari, M., Gagné, V., St-Onge, P., Tremblay-Dauphinais, P., Beaulieu, P., Théorêt, Y., Nava, T., Mlakar, V., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6821862/v1 · Cited by 1
HLA-Resolve: Four-field HLA typing and MHC variant detection from long-read hybrid capturePreprint
Glasenapp, M. R., Yee, M., Symons, A. E., Sheh, J. G., Garcia, O. A., & Cornejo, O. E. (2026) · medRxiv · doi:10.64898/2026.03.27.26349549 · Cited by 1
Spellman, S. R., & Shaw, B. E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316335727.009
Self-citationDonor Selection for Allogeneic Hematopoietic Cell Transplants: A Moving Target
Abutalib, S. A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316335727.008
The functional role of B cells and their secreted antibodies: in transplantation and cancer
Habets (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170322th
Dressel, R. (2017) · Transfusionsmedizin · doi:10.1055/s-0043-113801
Special Care of Blood and Marrow Hematopoietic Cell Transplant Recipient
Abutalib, S. A., & Lazarus, H. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-64263-5_57
HLA typing-A case-based approach to donor selection
Mayor, N. P., & Shaw, B. E. (2018) · Advances in Cell and Gene Therapy · doi:10.1002/acg2.16
“lation between the permissivity of a DPB1 allele and the expression levels of those alleles on the cell surface.(20,21) In light of these consistent findings, avoidance of an HLA‐DPB1 nonpermissively mismatched URD is recommended (where a matched/permissively”
BackgroundCharakterisierung eines HLA-DP spezifischen T-Zell Rezeptors
Zwerger, M. (2018) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.37993
Huang, H., Vierra‐Green, C., Spellman, S., & Kennedy, C. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/605428
“, the minor histocompatibility antigen (MiHA) single nucleotide polymorphisms (SNPs)[1], and SNPs that modify gene functions [2].”
BackgroundSelf-citationHuang, H. (2019) · University of Minnesota Digital Conservancy (University of Minnesota)
Mytilineos, D. (2018) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-17921
Prospecting the MHC: A Bioinformatic View of HLA Polymorphism and Gene Organization
Matern, B. M. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20200325bm
HLA MATCHING IN HEMATOPOIETIC STEM CELL TRANSPLANTATION: WHERE DO WE STAND?
Tsamadou, C. (2019) · Hospital chronicles/Hospital Chronicles · doi:10.2015/hc.v14i3.873
“Specifically, alleles in linkage with the rs9277534A were found by means of a quantitative polymerase-chain-reaction assay to be lower expressed compared to the rs9277534G alleles.(48) Petersdorf et al in the same study(48) including 1441 11/12 MUD transplants, observed that rs9277534G-linked HLA-DPB1 MM conferred hig…”
ResultMontero-Martín, G. (2021) · Docta Complutense (Universidad Complutense de Madrid)
The Human Leukocyte Antigen System in Psychiatry: Where Do We Stand?
Tamouza, R., Krishnamoorthy, R., & Leboyer, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-71229-7_10
Centro Párraga: interdisciplinar y ecuménico
Galán, F. M. (2002) · Sublime: arte + cultura contemporánea
Paczesny, S., & Kean, L. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812630-1.00020-7
Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM
Meurer, T., Crivello, P., Metzing, M., Kester, M., Megger, D. A., Chen, W., van Veelen, P. A., van Balen, P., Westendorf, A., Homa, G., et al. (2020) · immuneACCESS · doi:10.21417/tm2020i
The HLA System in Transfusion Medicine and Transplantation
(2016) · Transfusion Medicine · doi:10.1002/9781119236504.ch16
Avoiding a mismatch to limit GVHD
(2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.150
Zou, J., Kongtim, P., Oran, B., Srour, S. A., Greenbaum, U., Carmazzi, Y., Rondón, G., Ciurea, S. O., Ma, Q., Shpall, E. J., et al. (2023) · Cancer · doi:10.1002/cncr.34671
Covid-19, HLA, and race common link: A novel hypothesis
Chandrasekar, N. R., & Cajigas, H. E. (2023) · Transplant Immunology · doi:10.1016/j.trim.2023.101859
Hematopoietic Cell Transplantation
Petersdorf, E. W. (2023) · Springer eBooks · doi:10.1007/978-3-031-38058-7_3
Self-citationAskar, M. Z., Mosbruger, T. L., Shaw, G. T.-W., Kim, H., Duan, Y., Allen, A. S., Duke, J. L., Olson, T. S., Monos, D. S., & Hayeck, T. J. (2024) · medRxiv · doi:10.1101/2024.09.13.24313580
“21 The expression allele was imputed by matching the reported DPB1 typing with previously reported exon 2, exon 3 and rs9277534 linkages.”
MethodNovel Scoring System for Ranking Hematopoietic Stem Cell Transplantation
Baxter‐Lowe, L. A., Wang, T., Kuxhausen, M., Spellman, S. R., Maiers, M. J., Lee, S. J., Saultz, J. N., Arrieta‐Bolaños, E., Gadalla, S. M., Bolon, Y., et al. (2024) · Clinical Transplantation · doi:10.1111/ctr.15478
Self-citationHuman Leukocyte Antigen Biology and Genetics
Zhang, B. M., & Fernández-Viña, M. (2024) · Wiley eBooks · doi:10.1002/9781683674023.ch111
Lukanov, T., Mihaylova, A., Hadra, B. A., Lesichkova, S., Georgieva, A., Popov, T., Krasteva, Y., Mondeshki, T., & Naumova, E. J. (2025) · Human Immunology · doi:10.1016/j.humimm.2024.111228
Potential Impact of HLA DQB1*05 on Identical Sibling Hematopoietic Stem Cell Transplantation Outcome
Lawati, F. A., Al-Khabori, M. K., Harasi, S. A., & Al-Ansari, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14196798
Chen, Y., Zhan, W., Zhang, Y., Gao, H., Han, Y., Qiao, J., Li, Z., Liu, Y., Li, Y., Yang, S., et al. (2025) · medRxiv · doi:10.64898/2025.12.10.25342012
Elucidating the interconnection of GvHD and Western diet-induced atherosclerosis
Jorgacevic, I. (2024) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-32579
Neidlinger, E. (2024) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.58000
Rogowski-Effenberger, O. (2024) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-38762
Higuchi, T., Oka, S., Furukawa, H., Tohma, S., Yatsuhashi, H., & Migita, K. (2021) · Figshare · doi:10.6084/m9.figshare.13662819
Wißkirchen, J. (2021) · Gutenberg Open Science · doi:10.25358/openscience-6604
Neuber, L. M. (2023) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.54570
Bühler, S. (2023) · Archive ouverte UNIGE (University of Geneva) · doi:10.13097/archive-ouverte/unige:172722
Higuchi, T., Oka, S., Furukawa, H., Tohma, S., Yatsuhashi, H., & Migita, K. (2021) · Figshare · doi:10.6084/m9.figshare.13662822
The role of zinc in thymic regeneration after bone marrow transplant
Iovino, L. (2019) · Electronic Theses and Dissertations Repository (University of Pisa)
De klinische betekenis van HLA mismatch load bij nier- en longtransplantatie
Daniëls, L. (2025) · Lirias (KU Leuven)
The role of HLA transcription in unrelated hematopoietic cell transplantation
Morishima, S., Shiina, T., Azuma, F., Tomori, S., Doki, N., Nishida, T., Fukuda, T., Eto, T., Kataoka, K., Hasegawa, Y., et al. (2026) · Blood Advances · doi:10.1182/bloodadvances.2025017945
“The effect of the AST level of HLA-DPB1 on transplant outcomes requires further analysis.”
InfluentialCarey, S. (n.d.) · Research Explorer (The University of Manchester)
Peereboom, E. T. M., Jonker, J., Geneugelijk, K., van Zuilen, A. D., Bungener, L. B., Lunel, F. M. V., Sanders, J., Bakker, S. J. L., & Spierings, E. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1713932
Naidoo, L. (2024) · ResearchSpace (University of KwaZulu-Natal)
Etude des mécanismes d'expression des ligands de NKG2D lors des syndromes lymphoprolifératifs
Ilias, W. (2017) · theses.fr (ABES) · doi:10.70675/e80e800ezf973z460dz8a42z437fdd7579df
Loschi, M. L. (2018) · theses.fr (ABES) · doi:10.70675/17e135c8z9669z4080z9651z611bcbd8df0a
HLA Class II Protein Expression Regulation Is Strongly Linked to Cis‐Acting SNPs
Vince, N., Ramsuran, V., Viard, M., Martinson, J. J., Wolinsky, S. M., Hussain, S., Seaberg, E. C., Brown, T. T., Spence, N., Thio, C. L., et al. (2026) · HLA · doi:10.1111/tan.70669
Self-citationCarter, M., Park, S., Taniguchi, M., Otoukesh, S., Yang, D., Rao, P., Arslan, S., Shouse, G., Ali, H., Gendzekhadze, K., et al. (2026) · Bone Marrow Transplantation · doi:10.1038/s41409-026-02954-6
Yuan, C., Wang, N., Yuan, F., Zhao, Y., & Wang, X. (2026) · HLA · doi:10.1111/tan.70848
Human Leukocyte Antigen (HLA) Testing
Jain, D., & Lázár‐Molnár, E. (2026) · Springer eBooks · doi:10.1007/978-3-032-26557-9_18
Pagliuca, S., Mooyaart, J., Ayuk, F. A., Zeiser, R., Potter, V. T., Dreger, P., Bethge, W. A., Hilgendorf, I., Michonneau, D., Rambaldi, A., et al. (2026) · Blood Advances · doi:10.1182/bloodadvances.2026020341
Kozhokar, P. V., Yudintseva, O. S., Paina, O. V., Tsvetkova, L. A., Rakhmanova, Z. Z., Zakharov, E. E., Королева, Е. Е., Bykova, T. A., Semenova, E. V., & Zubarovskaya, L. S. (2026) · Pediatric Hematology/Oncology and Immunopathology · doi:10.24287/j.1152
HLA compatibility in hematopoietic stem cell transplantation
Kanda, J. (2026) · Major Histocompatibility Complex · doi:10.12667/mhc.33.113
Turner, T. R., Cambridge, C. A., Lucas, J. A. M., French, A. J. E., Hewerdine, S., Voiniciuc, D. F., Tierney, M. C., Barker, D. J., Lawson, S., Amrolia, P. J., et al. (2026) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2026.09.033
Metadata
- Authors
- Petersdorf, E. W., Malkki, M., O’hUigin, C., Carrington, M., Gooley, T., Haagenson, M. D., Horowitz, M. M., Spellman, S. R., Wang, T., & Stevenson, P.
- Affiliations
- University of Washington (US)
- Fred Hutch Cancer Center (US)
- Ragon Institute of MGH, MIT and Harvard (US)
- Medical College of Wisconsin (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-08-13
- Volume
- 373
- Issue
- 7
- Pages
- 599-609
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4560117
- OpenAlex
- W2258080942
- Cited by
- 278
- References
- 32
- Citations by year
- 2026: 12 · 2025: 9 · 2024: 26 · 2023: 18 · 2022: 20 · 2021: 25 · 2020: 24 · 2019: 33 · 2018: 36 · 2017: 41 · 2016: 30 · 2015: 3
- FWCI
- 28.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Defense (N000141310039)
- Frederick National Laboratory for Cancer Research (HHSN261200800001E.)
- National Institutes of Health (N00014-12-1-0142, #HHSN261200800001E, HHSN261200800001C, CA 18029)
- U.S. Public Health Service (HHSH234200637015C)
- U.S. Navy
- National Heart, Lung, and Blood Institute (U01HL069294)
- Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028, N00014-12-1-0142, N00014-12-1, N00014)
- National Cancer Institute (CA18029, U24CA76518, HHSN261200800001E), CA76518, CA100019, P30CA015704, U24CA076518, R01CA100019, P01CA018029)
- National Institute of Allergy and Infectious Diseases (AI069197, U01AI069197)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- HLA-DPB1, HLA-DPB1 mismatch, unrelated donor transplantation, post-transplant mortality, hematopoietic stem cell transplantation
- MeSH terms
- Adolescent, Adult, Female, Genotype, Graft vs Host Disease, Histocompatibility Testing, Humans, Genetic Linkage, Male, Middle Aged, Regulatory Sequences, Nucleic Acid, Proportional Hazards Models, Polymerase Chain Reaction, Hematopoietic Stem Cell Transplantation, Polymorphism, Single Nucleotide, Young Adult, HLA-DP beta-Chains, Unrelated Donors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.